A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
|Articles|January 19, 2022
Pharmacy Clinical Pearl of the Day: Geographic Tongue
Author(s)Saro Arakelians, PharmD
Treatment for geographic tongue includes OTC pay relievers, mouth rinses with anesthetics, antihistamines, corticosteroids, and vitamin B supplements.
Advertisement
Clinical Pearl of the Day: Geographic Tongue
Geographic tongue is an inflammatory but harmless condition affecting the surface of the tongue.
Insight:
- The tongue is normally covered with tiny, pinkish-white bumps (papillae), which are short, fine, hairlike projections.
- With geographic tongue, patches on the surface of the tongue are missing papillae and appear as smooth, red "islands," often with slightly raised borders.
- These patches (lesions) give the tongue a map-like, or geographic, appearance.
- The lesions often heal in one area and then migrate to a different part of the tongue.
- Geographic tongue is also known as benign migratory glossitis.
- Symptoms include smooth, red, and irregular shaped patches; frequent changes in the location, size, and shape discomfort and pain.
- Risk factors may include family history and fissured tongue.
- Treatment includes OTC pay relievers, mouth rinses with anesthetics, antihistamines, corticosteroids, and vitamin B supplements.
Reference:
Advertisement
Related to this article
A Novo Nordisk-funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, though the findings cannot show causation.
Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Phase 3 TRIUMPH-2 data presented at EASD show HbA1C reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
4
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
5